Search by Drug Name or NDC

NDC 00023-6153-08 OXYTROL 3.9 mg/d Details

OXYTROL 3.9 mg/d

OXYTROL is a TRANSDERMAL PATCH in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Allergan, Inc.. The primary component is OXYBUTYNIN.

MedlinePlus Drug Summary

Oxybutynin transdermal patches are used to treat an overactive bladder (a condition in which the bladder muscles contract uncontrollably and cause frequent urination, urgent need to urinate, and inability to control urination). Oxybutynin is in a class of medications called antimuscarinics. It works by relaxing the bladder muscles.

Related Packages: 00023-6153-08
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Oxybutynin Transdermal Patch

Product Information

NDC	00023-6153
Product ID	0023-6153_3919a14c-f563-4ae9-8774-fc2543f18d12
Associated GPIs	54100045008720
GCN Sequence Number	051909
GCN Sequence Number Description	oxybutynin PATCH TDSW 3.9MG/24HR TRANSDERM
HIC3	R1A
HIC3 Description	URINARY TRACT ANTISPASMODIC/ANTIINCONTINENCE AGENT
GCN	19363
HICL Sequence Number	025056
HICL Sequence Number Description	OXYBUTYNIN
Brand/Generic	Brand
Proprietary Name	OXYTROL
Proprietary Name Suffix	n/a
Non-Proprietary Name	Oxybutynin
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	PATCH
Route	TRANSDERMAL
Active Ingredient Strength	3.9
Active Ingredient Units	mg/d
Substance Name	OXYBUTYNIN
Labeler Name	Allergan, Inc.
Pharmaceutical Class	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]
DEA Schedule	n/a
Marketing Category	NDA
Application Number	NDA021351
Listing Certified Through	2024-12-31

Package

NDC 00023-6153-08 (00023615308)

Pricing Information	N/A
NDC Package Code	0023-6153-08
Billing NDC	00023615308
Package	8 POUCH in 1 BOX (0023-6153-08) / 1 PATCH in 1 POUCH / 4 d in 1 PATCH
Marketing Start Date	2003-02-26
NDC Exclude Flag	N